Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Research use must comply with all local and institutional regulations
Additional preclinical work describes interaction with the nitric oxide system and upregulation of growth hormone receptor in tendon fibroblasts
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
G.RamerM
58 Yajnik, C
It is not intended for diagnosis, treatment, or prevention of any condition , and must only be used in controlled laboratory environments by qualified professionals.
US$ 27.96
US$ 27.06
US$ 20.84
US$ 22.40
US$ 26.39
US$ 23.64
US$ 23.75
US$ 25.70
